Vir Biotechnology (VIR) Receivables - Accured (2020 - 2024)
Vir Biotechnology (VIR) reported Receivables - Accured of $5.7 million for Q1 2024, up 171.4% from $2.1 million a year earlier and up 42.5% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Receivables - Accured (2020 - 2024) Analysis & Trends
At the end of FY2023, Vir Biotechnology posted Receivables - Accured of $4 million, up 60.0% from FY2022.
- Receivables - Accured has increased for three consecutive years, with a three-year compound annual growth rate of 71.0% (FY2020 to FY2023).
- By year, Receivables - Accured came in at $2.5 million in FY2022 (+127.3%), $1.1 million in FY2021 (+37.5%) and $800,000 in FY2020.
- The Q1 2024 figure ranks as the highest quarterly Receivables - Accured in data going back to Q4 2020.
- Year over year, Receivables - Accured has now increased in each of the last eight quarters, with growth averaging 113.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Receivables - Accured ran from 0.0% in Q1 2022 to 250.0% in Q3 2022.
- Per Business Quant data, the three quarters before Q1 2024 came in at $4 million (Q4 2023), $2.9 million (Q3 2023) and $1.9 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 800,000.00 |
| Jun 30, 2021 | 600,000.00 |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 800,000.00 |
API Access
Vir Biotechnology Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();